Cannabis Watch: Hemp’s Million-Dollar Moment

Monday I revealed something about me that only the closest friends and family know.

In case you missed Monday’s issue, I’ll reveal this surprising truth again.

In 1991 I was diagnosed with non-Hodgkin’s lymphoma. In those day I was given two treatment options. If one or the other didn’t work, then there was nothing medically that could be done to save my life.

Thankfully I was fortunate and my treatment worked… and I have been in remission ever since.

This life-changing experience is the main reason why biotech companies and trading these stocks is so fascinating to me.

If it wasn’t for the research these companies do, I may not be here to tell you my story.

Or explain why enduring the rigors of cancer treatments in the ’90s also fuels my interest in the legal medical cannabis industry.

The side effects most folks endure when undergoing chemotherapy or oncology procedures can be as bad as the symptoms of the cancer itself.

Thankfully, flashing-forward to now, governments and the medical community are realizing the power of cannabis as medicine.

And cannabis uses for helping cancer patients are only the tip of the iceberg. Allow me to tell you the story of 6-year-old Charlotte Figi.

Suffered 300 Seizures a Week

Charlotte was a 6-year-old girl who was dealing with 300 grand mal seizures each and every week.

Charlotte was suffering from severe myoclonic epilepsy of infancy, or what is now referred to as Dravet syndrome. She tried everything in the book from Ativan to acupuncture. Nothing worked.

Finally, her parents turned to CBD.

After a short spurt of using CBD, Charlotte’s seizures went down a remarkable amount — from 300 a week to two–three a month. The results were amazing.

It was hard for naysayers to deny the power of CBD at that point.

Her story and these products gave true hope to others suffering from similar ailments.

And it’s these stories that only further solidify my belief that not only is the cannabis sector ripe with profit chances… It’s an industry you can feel good supporting on an ethical level.

Where Does CBD Come From?

You get it from hemp plants.

Hemp is a chemically different form of cannabis. It has little to no THC, the psychoactive component known for getting folk “high.”

Back in December, the Hemp Farming Act of 2018 was signed into law as part of a U.S. agriculture bill.

The new law allows for the farming of hemp in the U.S. for the first time in decades.

The signing of the bill could create a profit boom for medical marijuana companies with CBD products for sale on the open market…

To keep pace with this new development, the FDA will be working on how to better regulate legal hemp-derived CBD-containing supplements, foods and beverages.

Once the dust settles, companies operating in the CBD space will be able to procure new sources of potentially cheaper hemp-derived CBD, rather than limit themselves to imports.

This means less overhead and potentially higher profits. Which in turn will benefit you as a stakeholder in this space.

More on this soon.

For Technology Profits Daily,

Greg Guenthner

Ray Blanco
Chief Technology Expert, Technology Profits Daily

You May Also Be Interested In:

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, Ray Blanco’s FDA Trader, Penny Pot Profits, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco